Clinical Predictors of Ketamine Response in Treatment-Resistant Major Depression

OBJECTIVE: The N-methyl-D-aspartate receptor antagonist ketamine has rapid antidepressant effects in treatment-resistant major depressive disorder (MDD) and bipolar depression. Clinical predictors may identify those more likely to benefit from ketamine within clinically-heterogeneous populations. ME...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Clin Psychiatry
Autori principali: Niciu, Mark J., Luckenbaugh, David A., Ionescu, Dawn F., Guevara, Sara, Machado-Vieira, Rodrigo, Richards, Erica M., Brutsche, Nancy E., Nolan, Neal M., Zarate, Carlos A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2014
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4310499/
https://ncbi.nlm.nih.gov/pubmed/24922494
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.13m08698
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi